Original price was: $439.99.Current price is: $180.00.

In Stock

Total Size:
Digital products: Get the download link at Account or directly via email.
Support: Lifetime
Download: Unlimited Of Course 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman

PURCHASE THIS COURSE, YOU ACCUMLATE: 180 POINTs!


Category:

Description

Buy 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman Course at esyGB. You will have immediate access to the digital downloads in your account or your order email.

Total Size:
Digital products: Get the download link at Account or directly via email.
Support: Lifetime
Download: Unlimited Of Course 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman

Purchase 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman courses at here with PRICE $439.99 $180


When purchasing 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman course, You can get it with the LIFETIME SUPPORT and UNLIMITED DOWNLOAD.


2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman

Alzheimer’s disease and other neurocognitive disorders are disabling health conditions that create daunting challenges to patients, families and clinicians.

Are you prepared to manage and anticipate the complex patient needs that emerge when caring for these patients?

Have there been times in the past that you wished you had done more…?

Catherine Wollman, DNP, CRNP, GNP-BC, will provide the very latest research about who’s at risk, what’s at stake, and what we can realistically do to manage the impact of neurocognitive disorders.

Knowledge and evidence in dementia care are constantly changing. We will focus on the newest science, but also the use of ingenuity and compassion to address the multiple problems facing patients and families.

Unique clinical challenges will be reviewed using personal stories and case studies to decide the best pharmacological and non-pharmacological interventions to transform your own practice.

Alzheimer’s disease and other neurocognitive disorders will touch almost all of us personally or professionally.

During this intense recording, Catherine will provide you with new clinical insights and critical thinking skills so that you won’t need to feel uncertain, frustrated or at risk anymore!


  1. Differentiate cognitive impairment, dementias, neurocognitive disorders and their unique symptoms and trajectories.
  2. Review new DSM5™ changes and updated research on neurocognitive disorders.
  3. Evaluate the current status of dementia research, including new risks, causes and prevention of Alzheimer’s disease.
  4. Summarize screening tools and diagnostic methods for neurocognitive disorders.
  5. Recognize the impact of neurocognitive disorders/ dementias on the individual, family, caregivers and healthcare providers.
  6. Develop a comprehensive interdisciplinary plan of care for the patient and family with neurocognitive disorders/ dementias.
  7. Synthesize evidence-based interventions for behavioral and psychological symptoms of dementia.
  8. Discuss pharmacologic therapy for neurocognitive disorders/ dementias, delirium and depression.
  9. Summarize clinical updates on delirium from prevention and early recognition to effective management.
  10. Examine ethical issues related to neurocognitive disorders including capacity, safety, diagnosis disclosure, palliative and end of life care.
  11. Improve quality of life and outcomes of care for patients and families with neurocognitive disorders/ dementias.
  12. Analyze case studies of complex patients with neurocognitive disorders/ dementias.

Neurocognitive Disorders, Dementia and Cognitive Impairment

  • DSM-5™ changes and terminology
  • Aging and neurodegeneration
  • New research related to pathophysiology, diagnosis, risk factors and prevention

Differentiate Neurodegenerative Disorders

  • Alzheimer’s disease
  • Vascular disease
  • Frontotemporal disorder
  • Lewy body disease
  • Traumatic Brain Injury

Update on Delirium

  • Acute or persistent delirium
  • Screening and diagnosis
  • Prevent life threatening consequences
  • Evidence-based medications and treatment
  • Long term consequences

Diagnosis of Neurocognitive Disorders/Dementias

  • Reversible dementia-like disorders and conditions
  • Validated cognitive screening tools
  • New diagnostic criteria and stages of dementia
  • Family response to diagnosis

Pharmacologic Therapies for Neurocognitive Disorders/Dementias

  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Antidepressants
  • Antipsychotics and other psychotropic drugs
  • Evaluate new drugs and learn medications to avoid
  • Consider risk, side effects, and efficacy for older adults

Behavioral and Psychological Symptoms of Dementia (BPSD)

  • Vast majority of patients with one or more BPSD
  • Serious negative consequences of untreated behaviors
  • Tools to systematically assess the presence and severity of symptoms
  • Investigation of multiple contributing factors
  • Interdisciplinary creation and evaluation of a treatment plan

Interventions for Common Distressing Behaviors

  • Agitation, anxiety and restlessness that lead to emotional distress and disability
  • Apathy that contributes to poor prognosis and increased mortality
  • Sexually inappropriate behaviors – one of the most distressing behaviors
  • Frustration of changing behaviors over time

Best Practice for Unique Challenges

  • Eliminate pain-inducing factors to diminish behaviors
  • Nutrition and hydration challenges with disease progression
  • Sleep disorders and evidencebased management
  • Depression and effective therapy
  • Psychotic symptoms: Nonpharmacological and pharmacological interventions

Ethical Issues

  • Safety, function and autonomy
  • Comfort and dignity
  • Advance care planning
  • Palliative care and hospice
  • Genetic testing
  • Disclosure of diagnosis

Patient/Family Needs Across the Disease Trajectory

  • Professional and family caregivers
  • Community Resources

Case Studies and Clinical Stories


Are you interested in? neurocognitive disorders list; neurocognitive disorder unspecified; neurocognitive disorders; neurocognitive academy; neurocognitive domains


Purchasing 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman course now, You can get it with the LIFETIME SUPPORT and UNLIMITED DOWNLOAD.

Purchase 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman courses at here with PRICE $439.99 $180

Buy the 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman course at the best price at esy[GB]. Upon completing your purchase, you will gain immediate access to the downloads page. Here, you can download all associated files from your order. Additionally, we will send a download notification email to your provided email address.

Unlock your full potential with 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman courses. Our meticulously designed courses are intended to help you excel in your chosen field.

Why wait? Take the first step towards greatness by acquiring our 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman courses today. We offer a seamless and secure purchasing experience, ensuring your peace of mind. Rest assured that your financial information is safeguarded through our trusted payment gateways, Stripe and PayPal.

Stripe, known for its robust security measures, provides a safe and reliable payment process. Your sensitive data remains confidential throughout the transaction thanks to its encrypted technology. Your purchase is fully protected.

PayPal, a globally recognized payment platform, adds an extra layer of security. With its buyer protection program, you can make your purchase with confidence. PayPal ensures that your financial details are safeguarded, allowing you to focus on your learning journey.

Is it secure? to Use of?
How can this course be delivered?
What Shipping Methods Are Available?
How Do I Track Order?
  • We promptly update the status of your order after your payment is completed. If, after 7 days, there is no download link, the system will automatically process a refund.
  • We value your feedback and are eager to hear from you. Please do not hesitate to reach out via email us with any comments, questions and suggestions.
Shop
Sidebar
0 Cart
2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues- M. Catherine Wollman
Original price was: $439.99.Current price is: $180.00. Add to cart